OB 001 - Oisin Biotechnologies
Alternative Names: OB-001 - Oisin BiotechnologiesLatest Information Update: 02 Jun 2021
At a glance
- Originator Oisin Biotechnologies
- Class Gene therapies; Urologics
- Mechanism of Action Caspase 9 expression stimulants; Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Renal failure